@misc{indiciae206aaa142141,
  title = {Clinical and molecular characterisation of primary refractoriness to atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma.},
  author = {Lombardi, P. and Ramon-Gil, E. and Brunetti, L. and Manfredi, G. F. and Merces, G. and Fulgenzi, C. A. M. and DAlessio, A. and Torkpour, A. and Celsa, C. and Stefanini, B. and Yang, H. and Crowley, F. and Marron, T. U. and Saeed, A. and Pinter, M. and Scheiner, B. and Huang, Y.-H. and Lee, P.-C. and Nishida, N. and Po-Ting Lin, R. and Dalbeni, A. and Vivaldi, C. and Masi, G. and Rohlen, N. and von Felden, J. and Kaseb, A. and Galle, P. R. and Kudo, M. and Hsu, W.-F. and Rimassa, L. and Parisi, A. and Kelley, R. K. and Toyoda, H. and Pirisi, M. and Jabar, R. F. and Rakaee, M. and Cabibbo, G. and Camma, C. and Piscaglia, F. and Hwang, S. and Shin, D. J. and Li, M. and Daniele, G. and Mann, D. and Chon, H. J. and Leslie, J. and Pin},
  year = {2025},
  doi = {10.1101/2025.07.08.663653},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.08.663653v1},
  note = {Source identifier: 10.1101/2025.07.08.663653}
}